ATE193725T1 - Anti-felincalicivirus rekombinanter antikörper und dafür kodierendes gen - Google Patents

Anti-felincalicivirus rekombinanter antikörper und dafür kodierendes gen

Info

Publication number
ATE193725T1
ATE193725T1 AT93103066T AT93103066T ATE193725T1 AT E193725 T1 ATE193725 T1 AT E193725T1 AT 93103066 T AT93103066 T AT 93103066T AT 93103066 T AT93103066 T AT 93103066T AT E193725 T1 ATE193725 T1 AT E193725T1
Authority
AT
Austria
Prior art keywords
antibody
fcv
feline
recombinant antibody
gene fragment
Prior art date
Application number
AT93103066T
Other languages
English (en)
Inventor
Kazuhiko Kimachi
Hiroaki Maeda
Kiyoto Nishiyama
Sachio Tokiyoshi
Yukinobu Tohya
Takeshi Mikami
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE193725T1 publication Critical patent/ATE193725T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT93103066T 1992-02-28 1993-02-26 Anti-felincalicivirus rekombinanter antikörper und dafür kodierendes gen ATE193725T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7918992 1992-02-28

Publications (1)

Publication Number Publication Date
ATE193725T1 true ATE193725T1 (de) 2000-06-15

Family

ID=13683035

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93103066T ATE193725T1 (de) 1992-02-28 1993-02-26 Anti-felincalicivirus rekombinanter antikörper und dafür kodierendes gen

Country Status (7)

Country Link
US (1) US5785968A (de)
EP (1) EP0561194B1 (de)
AT (1) ATE193725T1 (de)
AU (1) AU661106B2 (de)
CA (1) CA2090515C (de)
DE (1) DE69328799T2 (de)
ES (1) ES2149182T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1606391B1 (de) * 2003-03-14 2011-01-19 Regents of the University of California Virulentes systemisches felines calicivirus
US7309495B2 (en) * 2003-03-14 2007-12-18 The Regents Of The University Of California Hemorrhagic feline calicivirus
DE102011118031B4 (de) 2011-06-23 2013-08-01 Technische Universität Dresden Calicivirus bindende Peptide, dafür kodierende Nukleinsäuren, deren Verwendungen und Verfahren und Kits zur Anreicherung, Immobilisierung und zum Nachweis von Caliciviren
US9901478B2 (en) 2014-03-11 2018-02-27 Chine, Llc Methods and apparatuses for the external distraction in the assistance of spinal deformities
CN115141273B (zh) * 2022-06-21 2024-02-06 泰州博莱得利生物科技有限公司 一种猫杯状病毒的单克隆抗体及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944469A (en) * 1974-11-21 1976-03-16 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
US3937812A (en) * 1974-11-21 1976-02-10 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPH01309785A (ja) 1988-06-06 1989-12-14 Babcock Hitachi Kk ミドルパルスｔｉｇ溶接装置
ATE119545T1 (de) * 1989-07-21 1995-03-15 Upjohn Co Felincalicivirus-capsid-protein und nukleotidsequenz.
AU632843B2 (en) * 1989-08-10 1993-01-14 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Cat-mouse heterohybridoma and gene fragment coding for constant region of feline immunoglobulin

Also Published As

Publication number Publication date
EP0561194A3 (en) 1994-08-24
CA2090515A1 (en) 1993-08-29
AU3391193A (en) 1993-09-02
DE69328799T2 (de) 2000-10-26
EP0561194B1 (de) 2000-06-07
EP0561194A2 (de) 1993-09-22
AU661106B2 (en) 1995-07-13
CA2090515C (en) 2002-10-29
ES2149182T3 (es) 2000-11-01
DE69328799D1 (de) 2000-07-13
US5785968A (en) 1998-07-28

Similar Documents

Publication Publication Date Title
ATE199745T1 (de) Rekombinanter antikörper gerichtet gegen das feline herpesvirus-1 und dafür kodierendes genfragment
ATE139900T1 (de) Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma
ATE305971T1 (de) Monoklonale antikörper und fv gegen das cd2 antigen
DE69535243D1 (de) Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
DK121788A (da) Il-6, fremgangsmaade til dets fremstilling samt dets anvendelse
PT1005870E (pt) Aplicação terapêutica de anticorpos quiméricos contra antigénio de diferenciação restrita de linfócitos b humanos, para o tratamento do linfoma de células b
NO20014415L (no) Medisinske preparater til behandling av <alfa>-galaktosidase- A-defisiens
EP0261224A4 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
IL72985A0 (en) Homogenous immune interferon fragment,its manufacture and pharmaceutical compositions containing it
FI885807L (fi) Puhdistetun, biologisesti aktiivisen, bakteerien avulla tuotetun rekombinanttisen ihmis- CSF-1:n tuottaminen
BR9007702A (pt) Metodo de tratamento
DE68912155D1 (de) Antivirales Kombinationspräparat.
ATE193725T1 (de) Anti-felincalicivirus rekombinanter antikörper und dafür kodierendes gen
FI944561A7 (fi) HIV:tä neutraloivia monoklonaalisia yhdistelmähumaanivasta-aineita HIV -infektion ehkäisemiseksi ja hoitamiseksi
DE3854267D1 (de) HIV-spezifische monoklonale Antikörper und Hybridome zu ihrer Herstellung.
SE8404283L (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
FI853389A0 (fi) Tumoerlaekemedel och foerfarande foer dess framstaellning.
FI883723A7 (fi) Ihmisen monoklonaaliset vasta-aineet ja niitä vaikuttavana aineosana s isältävät terapeuttiset aineet infektiotauteja vastaan
IT1148013B (it) Procedimento per ottenere preparati di tossoplasmi per la diagnosi del la tossoplasmosi e preparati cosi' ottenuti
ZA873743B (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
DE3850933D1 (de) Anticoagulatorisches Protein PP4-X, seine Herstellung und Verwendung.
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
Khamitov The state of cholinergic reactions of saliva and blood in patients with odontogenic osteomyelitis of the jaws
Burnyasheva et al. On the question of the treatment of urticaria

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties